Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
1.570
+0.010 (0.64%)
Jan 21, 2025, 4:00 PM EST - Market closed
Nephros Market Cap
Nephros has a market cap or net worth of $16.55 million as of January 22, 2025. Its market cap has decreased by -54.52% in one year.
Market Cap
16.55M
Enterprise Value
15.59M
1-Year Change
-54.52%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $16.55M, a decrease of -69.40%. That is a compound annual growth rate of -19.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 16.60M | 7.10% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |